The global clinical trial imaging market size was valued at USD 1,286.2 billion in 2021 and is poised to grow at a significant CAGR of 7.9% during the forecast period 2022-28. Some of the key factors fueling the market growth include growth in the pharmaceutical and biotechnology industries, huge spending on R&D, rise in number of contract research organizations and advancements in the technology. Also, enhanced investment in medical imaging companies and adoption of innovative imaging technologies to support clinical trials are other factors responsible for the market growth.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-clinical-trial-imaging-market/

The rise in the number of pharmaceutical and biotechnology companies is making it imperative for the manufacturers to deliver the best possible drug or medicine to the end user as competition is striking the companies. For instance, IXICO provides a reading tool named Assessa, which helps in enhanced decision making in clinical trials for neurological disorders which include dementia, cognitive impairment and diseases related with memory such as Parkinson’s, Schizophrenia, and Alzheimer’s disease.

The global clinical trial imaging market segmentation:

1) By Product & Services: Software and Services.

2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography and Other Modalities.

3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes and Other End-Users.

North America accounted for larger revenue share in global clinical trial imaging market with considerable CAGR. The growth in this region is due to increasing geriatric population together with rising prevalence of chronic diseases and growing number of pharmaceutical and biotechnology companies. In addition, Asia Pacific held substantial market share during estimated period owing to soaring need for better diagnostic devices and demand for specialized and quality healthcare facilities to improve patient’s life. Europe held steady growth during predicted period as research laboratories are looking to reduce operational costs and rising adoption of clinical trial imaging techniques in this region.

Request sample report at  https://precisionbusinessinsights.com/request-sample/?product_id=38750  

The frozen yogurt market Baroclinic, Inc., Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies, LLC, Icon PLC, Intrinsic Imaging LLC, Ixico PLC, Parexel, International Corporation, Radiant Sage LLC, World care Clinical, LLC

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747